论文部分内容阅读
目的:探究生化检验项目在诊断肝硬化疾病中的临床效果。方法:选取我院2014年3月~2016年3月收治的肝硬化患者50例作为实验组,选取同期50例健康体检人员为对照组,观察两组人员生化检验项目结构。结果:两组ALP、AST、DBIL、TP、ALB、ALT生化指标结果对比差异显著具有统计学意义(P<0.05);两组人员在HA、PC-Ⅲ、LN、Ⅳ、Ⅳ-C纤维化指标检测结果中对比差异显著具有统计学意义(P<0.05)。结论:肝硬化患者在经由生化指标检验后,能够更为有效的辅助医生及时诊断病情,给予针对性的治疗方案,有助于提升临床治疗效果,对提升肝硬化患者的治愈率具有重要价值。
Objective: To investigate the clinical effects of biochemical tests in the diagnosis of cirrhosis. Methods: Fifty patients with cirrhosis who were treated in our hospital from March 2014 to March 2016 were selected as the experimental group, and 50 healthy subjects were selected as the control group in the same period to observe the biochemical test items structure of the two groups. Results: There was significant difference in the biochemical indexes of ALP, AST, DBIL, TP, ALB and ALT between the two groups (P <0.05) The difference of the index test results was statistically significant (P <0.05). Conclusion: After biochemical tests, patients with cirrhosis can be more effective in assisting physicians diagnosing the disease in time and giving targeted treatment plans, which can help improve clinical outcomes and have important value in improving the cure rate of cirrhotic patients.